Zevenbergen Capital Investments’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-698,859
| Closed | -$19.6M | – | 87 |
|
|
2021
Q4 | $19.6M | Sell |
698,859
-107,910
| -13% | -$3.03M | 0.41% | 37 |
|
|
2021
Q3 | $27.4M | Sell |
806,769
-222,345
| -22% | -$7.56M | 0.52% | 39 |
|
|
2021
Q2 | $42M | Buy |
1,029,114
+4,531
| +0.4% | +$185K | 0.75% | 36 |
|
|
2021
Q1 | $41.3M | Buy |
1,024,583
+27,334
| +3% | +$1.1M | 0.78% | 32 |
|
|
2020
Q4 | $59M | Buy |
997,249
+4,610
| +0.5% | +$273K | 1.03% | 30 |
|
|
2020
Q3 | $48.3M | Buy |
992,639
+215,049
| +28% | +$10.5M | 0.97% | 30 |
|
|
2020
Q2 | $37.6M | Buy |
777,590
+118,940
| +18% | +$5.75M | 0.9% | 35 |
|
|
2020
Q1 | $18.3M | Buy |
658,650
+335,990
| +104% | +$9.33M | 0.69% | 31 |
|
|
2019
Q4 | $9.65M | Buy |
+322,660
| New | +$9.65M | 0.36% | 34 |
|